Emergent BioSolutions Inc.EBSNYSE
Loading
Gross Profit Over TimeStable
Percentile Rank57
3Y CAGR-9.5%
5Y CAGR-16.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-9.5%/yr
vs +10.2%/yr prior
5Y CAGR
-16.5%/yr
Recent acceleration
Acceleration
-19.7pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$350.60M-6.6%
2024$375.40M+4.3%
2023$360.00M-23.9%
2022$473.00M-40.4%
2021$793.20M-8.1%
2020$863.10M+78.7%
2019$483.10M+50.8%
2018$320.40M+13.0%
2017$283.60M+15.8%
2016$244.80M-